World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
39167
World Ranking
7060
National Ranking
35

Thomas R. Pieber publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Thomas R. Pieber sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 742 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Thomas R. Pieber D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas R. Pieber sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Thomas R. Pieber is affiliated with the Medical University of Graz in Austria and has published extensively in the field of Medicine, with a particular focus on Endocrinology, Diabetes, and Metabolism. Their research spans several interconnected subfields including Genetics, Physiology, Surgery, and Molecular Biology, with a strong emphasis on diabetes-related studies.

Their main topics of work include diabetes management and research, diabetes treatment and management, pancreatic function and diabetes, and diabetes-associated disorders. Additionally, they have contributed to research on hyperglycemia and glycemic control in critically ill and hospitalized patients, diet and metabolism studies, and the intersection of metabolism, diabetes, and cancer.

Thomas R. Pieber has published in a wide range of academic venues. Frequent publication venues include:

  • Diabetes
  • Endocrine Abstracts
  • Diabetes Obesity and Metabolism
  • Neuro-Oncology
  • Diabetes Care

Coauthorship is a significant aspect of their research, with frequent collaborators being:

  • Christoph Haudum
  • Barbara Prietl
  • Barbara Obermayer-Pietsch
  • Harald Sourij
  • Julia K. Mader

An overview of some recent notable papers includes the following:

  • Empagliflozin in acute myocardial infarction: the EMMY trial, 2022, European Heart Journal
  • A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings, 2022, Journal of Diabetes Science and Technology
  • Dietary spermidine improves cognitive function, 2021, Cell Reports
  • Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial, 2021, The Lancet Diabetes & Endocrinology
  • Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial, 2022, Diabetes Care

Best Publications

  • Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes

    Roman Hovorka;Valentina Canonico;Ludovic J Chassin;Ulrich Haueter

  • Vitamin D and Immune Function

    Barbara Prietl;Gerlies Treiber;Thomas R. Pieber;Karin Amrein

  • Cardioprotection and lifespan extension by the natural polyamine spermidine

    Tobias Eisenberg;Mahmoud Abdellatif;Sabrina Schroeder;Uwe Primessnig;Uwe Primessnig

  • A desktop guide to Type 2 diabetes mellitus

    M. Aguilar;K. G.M.M. Alberti;S. A. Amiel;J. Azzopardi

  • Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

    Steven P. Marso;Darren K. Mcguire;Bernard Zinman;Neil R. Poulter

  • Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.

    Ele Ferrannini;Simona Baldi;Silvia Frascerra;Brenno Astiarraga

  • Long acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

    Karl Horvath;Klaus Jeitler;Andrea Berghold;Susanne H Ebrahim

  • Vitamin D status and arterial hypertension: a systematic review

    Stefan Pilz;Andreas Tomaschitz;Eberhard Ritz;Thomas R. Pieber

  • Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis

    K. Jeitler;K. Jeitler;K. Horvath;A. Berghold;T. W. Gratzer;T. W. Gratzer

  • Regulation of Autophagy by Cytosolic Acetyl-Coenzyme A

    Guillermo Mariño;Federico Pietrocola;Tobias Eisenberg;Yongli Kong

  • Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial.

    Karin Amrein;Christian Schnedl;Alexander Holl;Regina Riedl

  • Home Use of an Artificial Beta Cell in Type 1 Diabetes

    Hood Thabit;Martin Tauschmann;Janet M. Allen;Lalantha Leelarathna

  • Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.

    Melanie Davies;Thomas R. Pieber;Marie-Louise Hartoft-Nielsen;Oluf K. H. Hansen

  • Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.

    Elisabeth Wehr;Stefan Pilz;Natascha Schweighofer;Albrecht Giuliani

  • Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

    Andrea Siebenhofer;Johannes Plank;Andrea Berghold;Klaus Jeitler

  • Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner.

    Varun K Gupta;Lisa Scheunemann;Tobias Eisenberg;Sara Mertel

  • A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.

    Johannes Plank;Manfred Bodenlenz;Frank Sinner;Christoph Magnes

  • Vitamin D, cardiovascular disease and mortality

    Stefan Pilz;Andreas Tomaschitz;Winfried März;Winfried März;Winfried März;Christiane Drechsler

  • Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies.

    T. Heise;T. R. Pieber

  • Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.

    Lisa Lindheim;Mina Bashir;Julia Münzker;Christian Trummer

Frequent Co-Authors

Stefan Pilz
Stefan Pilz Medical University of Graz
Zlatko Trajanoski
Zlatko Trajanoski Innsbruck Medical University
Frank Madeo
Frank Madeo University of Graz
Simon Heller
Simon Heller University of Sheffield
Tobias Eisenberg
Tobias Eisenberg University of Graz
John B. Buse
John B. Buse University of North Carolina at Chapel Hill
Winfried März
Winfried März Medical University of Graz
Stephan J. Sigrist
Stephan J. Sigrist Freie Universität Berlin
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center
Guido Kroemer
Guido Kroemer Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can open up several career pathways in healthcare, especially if you’re considering medicine in the USA. Flexible online options make it possible to gain experience and credentials even before or during your medical studies.

Licensed Practical Nurses can advance their careers through fast track medical lpn programs, which offer a streamlined route to licensure. If you already have a BSN, you might consider the growing field of psychiatric care via bsn to np programs online, which provide convenient and accelerated pathways to becoming a Nurse Practitioner.

For those interested in the business side of healthcare, an online degree in administration can be a smart investment. You can control expenses by seeking the healthcare administration degree cost that suits your budget, or look for the cheapest online master degree in healthcare administration to maximize value.

No matter your professional goals, online programs make it easier to find the right fit and advance your career in the healthcare sector.

Best Scientists Citing Thomas R. Pieber

Trending Scientists

Recently Published Articles